W.L. Gore & Associates announced today that it agreed to acquire left atrial appendage occlusion (LAAO) device maker ...

NASHUA, N.H., Oct. 19, 2023 /PRNewswire/ -- Conformal Medical, Inc. announced today the one-year results from the company's CONFORMAL Early Feasibility Study (EFS) will be presented during the 2023 ...

The odds of complications and early mortality are higher among LAAO recipients with kidney impairment. Chronic kidney disease (CKD) and end-stage kidney disease (ESKD) increase the risks for ...

W. L. Gore & Associates, Inc. (Gore) a global materials science company dedicated to transforming industries and improving ...

Use of left atrial appendage occlusion (LAAO) for stroke prevention in patients with atrial fibrillation (AF) has increased rapidly in the United States since the technology was first approved in 2015 ...

Next-generation system to be highlighted during a technology innovation session and live case presentation by Professor Jens Erik Nielsen-Kudsk "With a single size, the CLAAS® AcuFORM™ implant can ...

Broad-based DRT detected on surveillance CT at 45 days after LAAO with Watchman FLX (Photo Credit: Mohamad Alkhouli) Device-related thrombus (DRT) that develops after left atrial appendage occlusion ...

NASHUA, N.H., Oct. 24, 2023 /PRNewswire/ -- Conformal Medical, Inc. announced today the positive one-year results from the company's CONFORMAL Early Feasibility Study (EFS). Dr. William Gray, ...

W L Gore & Associates to acquire medical device company, Conformal Medical to expand its presence in endovascular treatments: Newark, Delaware Wednesday, January 7, 2026, 15:00 Hr ...